Step 8 of 10 · Decision support
Treatment plan
What this step shows
The recommended next treatment step, following statin → ezetimibe → PCSK9 inhibitor and taking intolerance and time on therapy into account.
Clinical pathway
Special Category — Familial Hypercholesterolemia
Risk category
High
LDL-C target
<1.8 mmol/L
Recommended next step
At target — continue current therapy and monitor
LDL-C is already below target on the current regimen. No escalation needed; recommend routine monitoring.
Current therapy on record
Moderate-intensity statin (jj) · 1 month(s) on this regimen
· statin intolerance documented Edit
How this was decided
- ✓ LDL-C already at target? 0.6 mmol/L vs. target <1.8 mmol/L.